BRIEF-ThromboGenics cash 168.6 mln eur at end Q3

BRUSSELS Thu Nov 8, 2012 11:50am EST

Related Topics

BRUSSELS Nov 8 (Reuters) - Thrombogenics NV : * Says has EUR 168.6 million eur in cash as of 30 September versus EUR 88.3

million at the end of September 2011 * 9-mnth revenue 75.1 million euros versus 2.5 million EUR last time * Sees Jetrea launch in January 2013

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.